A Population-Based Clinical Trial of Irinotecan and Carboplatin

Table 4

Tumor types and best response to treatment. PR: partial response; SD: stable disease; PD: progressive disease; NA: not assessable.

Tumor types	Number of patients
	Total	PR	SD	PD	NA
Nonsmall-cell lung	21	5	7	3	6
Small-cell lung	10	4	3	2	1
Gastrointestinal	10	3	3	2	2
Head and neck	3	0	1	2	0
Miscellaneous	6	1	3	1	1
Total	50	13	17	10	10